Recovery Therapy Trial - Full Text View

Sponsors and Collaborators:	Melbourne Health William Buckland Foundation
Information provided by:	Melbourne Health
ClinicalTrials.gov Identifier:	NCT00239122

Purpose

This project will systematically apply a specialist version of Cognitive Behaviour Therapy (CBT), known as Recovery Therapy, to a random sample of patients with psychotic disorders. Previously, the therapy has been developed and efficacy established, but the extent of applicability to (unselected) mental health service patients is unknown. The main aim is to establish the extent to which this therapy is acceptable and effective for mental health service clients. A secondary aim is to develop guidelines for the conduct of such therapy in public mental health settings.

Condition	Intervention
Schizophrenia Psychotic Disorders Mood Disorders	Behavioral: Recovery Therapy (Cognitive Behaviour Therapy for psychosis)

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Applicability of CBT to Unselected Mental Health Service Clients With Psychotic Disorders

Resource links provided by NLM:

MedlinePlus related topics: Child Mental Health Mental Health Psychotic Disorders Schizophrenia

U.S. FDA Resources

Further study details as provided by Melbourne Health:

Primary Outcome Measures:

To determine the applicability of cognitive behaviour therapy for psychosis in the "real world" setting of ordinary mental health services

Secondary Outcome Measures:

To establish rates of uptake of Recovery Therapy amongst clients at a community mental health service
To establish effectiveness of therapy in clients who received a defined length of therapeutic contact (12-24 sessions)
To identify factors predicting uptake and effectiveness

Estimated Enrollment:	94
Study Start Date:	June 2000
Estimated Study Completion Date:	February 2004

Eligibility

Ages Eligible for Study:	16 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

acceptance by the participating Community Mental Health Services for case management
a preliminary DSM-IV diagnosis of schizophrenia, schizoaffective disorder, mood disorder with psychotic features, or delusional disorder
a recovery "need" in one of the areas addressed by the therapy

Exclusion Criteria:

a preliminary DSM-IV diagnosis of brief psychotic disorder, drug-induced psychosis, mood disorder without hallucinations or delusions, or any other disorder (eg. personality disorder, PTSD) even where psychotic features are/have been present
non-English speaking
comorbid intellectual disability

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00239122

Locations

Australia, Victoria
Whittlesea Community Mental Health Service
Epping, Victoria, Australia, 3076
Darebin Community Mental Health Service
Preston, Victoria, Australia, 3072

Sponsors and Collaborators

Melbourne Health

William Buckland Foundation

Investigators

Principal Investigator:

John Farhall, BA(Hons), MA

LaTrobe University, NorthWestern Mental Health

More Information

No publications provided

Study ID Numbers:	E00013
Study First Received:	October 12, 2005
Last Updated:	October 12, 2005
ClinicalTrials.gov Identifier:	NCT00239122 History of Changes
Health Authority:	Australia: National Health and Medical Research Council

Keywords provided by Melbourne Health:

Cognitive Therapy
Psychotic Disorders
Treatment Outcome

Study placed in the following topic categories:

Schizophrenia
Mental Disorders
Mood Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

Additional relevant MeSH terms:

Schizophrenia
Pathologic Processes
Disease
Mental Disorders

Mood Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on September 11, 2009